RT Journal Article
SR Electronic
T1 Childhood mortality during and after acute illness in sub-Saharan Africa and South Asia - The CHAIN cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.24.21266806
DO 10.1101/2021.11.24.21266806
A1 Diallo, Abdoulaye Hama
A1 Sayeem Bin Shahid, Abu Sadat Mohammad
A1 Khan, Al Fazal
A1 Saleem, Ali Faisal
A1 Singa, Benson O.
A1 Gnoumou, Blaise Siézan
A1 Tigoi, Caroline
A1 Achieng, Catherine
A1 Bourdon, Celine
A1 Oduol, Chris
A1 Lancioni, Christina L.
A1 Manyasi, Christine
A1 McGrath, Christine J.
A1 Maronga, Christopher
A1 Lwanga, Christopher
A1 Brals, Daniella
A1 Ahmed, Dilruba
A1 Mondal, Dinesh
A1 Denno, Donna M.
A1 Mangale, Dorothy I.
A1 Chimezi, Emmanuel
A1 Mbale, Emmie
A1 Mupere, Ezekiel
A1 Mamun, Gazi Md. Salauddin
A1 Ouédraogo, Issaka
A1 Berkley, James A.
A1 Njirammadzi, Jenala
A1 Mukisa, John
A1 Thitiri, Johnstone
A1 Carreon, Joseph D.
A1 Walson, Judd L.
A1 Jemutai, Julie
A1 Tickell, Kirkby D.
A1 Shahrin, Lubaba
A1 Mallewa, MacPherson
A1 Hossain, Md. Iqbal
A1 Chisti, Mohammod Jobayer
A1 Timbwa, Molly
A1 Mburu, Moses
A1 Ngari, Moses
A1 Ngao, Narshion
A1 Aber, Peace
A1 Harawa, Philliness Prisca
A1 Sukhtankar, Priya
A1 Bandsma, Robert H. J.
A1 Bamouni, Roseline Maïmouna
A1 Molyneux, Sassy
A1 Mwaringa, Shalton
A1 Shaima, Shamsun Nahar
A1 Ali, Syed Asad
A1 Afsana, Syeda Momena
A1 Banu, Syera
A1 Ahmed, Tahmeed
A1 Voskuijl, Wieger P.
A1 Kazi, Zaubina
YR 2021
UL http://medrxiv.org/content/early/2021/11/26/2021.11.24.21266806.abstract
AB Objectives Mortality during acute illness among children in low- and middle-income settings remain unacceptably high and there is increasing recognition of the importance of post-discharge mortality. A comprehensive understanding of pathways underlying mortality among acutely ill children is needed to develop interventions and improve guidelines. We aimed to determine the incidence, timing and contributions of proximal and underlying exposures for mortality among acutely ill young children from admission to hospital until 6 months after discharge in sub-Saharan Africa and South Asia in the context of guideline-based care.Design A prospective stratified cohort study recruiting acutely ill children at admission to hospital with follow up until 180 days after discharge from hospital (November 2016-July 2019).Setting Nine urban and rural hospitals in sub-Saharan Africa and South Asia across a range of facility levels, and local prevalences of HIV and malaria.Participants Inclusion criteria were age 2-23 months, admission to hospital with acute, non-traumatic medical illness and stratified into three groups by anthropometry. Children were excluded if currently receiving pulmonary resuscitation, had a known condition requiring surgery within 6 months or known terminal illness with death expected within 6 months.Main outcome measures Acute mortality occurring within 30-days from admission; post-discharge mortality within 180-days from discharge; characteristics with direct and indirect associations with mortality within a multi-level a priori framework including demographic, clinical, anthropometric characteristics at admission and discharge from hospital, and pre-existing child-, caregiver- and household-level characteristics.Results Of 3101 participants (median age 11 months), 1218 were severely wasted/kwashiorkor, 763 moderately wasted and 1120 were not wasted. Of 350 deaths, 182 (52%) occurred during index admission, 234 (67%) within 30-days of admission and 168 (48%) within 180-days post-discharge. Ninety (54%) post-discharge deaths occurred at home. The ratio of inpatient to post-discharge mortality was consistent across anthropometric strata and sites. Large high and low risk groups could be disaggregated for both early and post-discharge mortality. Structural equation models identified direct pathways to mortality and multiple socioeconomic, clinical and nutritional domains acting indirectly through anthropometric status.Conclusions Among diverse sites in Africa and South Asia, almost half of mortality occurs post-discharge. Despite being highly predictable, these deaths are not addressed in current guidelines. A fundamental shift to a risk-based approach to inpatient and post-discharge management is needed to further reduce childhood mortality and clinical trials of these approaches with outcomes of mortality, readmission and cost are warranted.Trial Registration ClinicalTrials.gov: NCT03208725Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.chainnetwork.org/resources https://bmjopen.bmj.com/content/9/5/e028454 Funding StatementThe CHAIN Network is supported by the Bill & Melinda Gates Foundation [OPP1131320]. Dr. Berkley was supported by the MRC/DFiD/Wellcome Trust Joint Global Health Trials scheme [MR/M007367/1] and study staffing, facilities and resources were contributed by the Wellcome Trust [203077_Z_16_Z]. Funders had no role in study design, implementation, analysis, interpretation or decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Oxford University Tropical Research Ethics Committee (34-16) and ethics committees at all participating institutions.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe CHAIN cohort data and analysis code are deposited at: https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/5H5X0P and may be requested via email to dgc{at}kemri-wellcome.org